| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC1653 |
| Trial ID | NCT02932956 |
| Disease | Liver Cancer |
| Altered gene | GPC3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GPC3 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP) |
| Year | 2018 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | H-39410- GAP|GAP |
| Vector information | |||||||
|
|||||||
| Cohort 1 | |||||||||||||||
|
|||||||||||||||